PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,688 | -83.0% | 321,856 | 0.0% | 0.00% | -80.0% |
Q3 2022 | $57,000 | -74.9% | 321,856 | -15.0% | 0.02% | -75.8% |
Q2 2022 | $227,000 | -54.6% | 378,611 | 0.0% | 0.06% | -52.3% |
Q1 2022 | $500,000 | -49.4% | 378,611 | 0.0% | 0.13% | -47.6% |
Q4 2021 | $988,000 | -47.3% | 378,611 | -37.2% | 0.25% | -50.1% |
Q3 2021 | $1,875,000 | -16.4% | 603,042 | 0.0% | 0.50% | +6.0% |
Q2 2021 | $2,243,000 | +7.5% | 603,042 | 0.0% | 0.47% | -5.3% |
Q1 2021 | $2,087,000 | +93.8% | 603,042 | +88.1% | 0.50% | +54.7% |
Q4 2020 | $1,077,000 | -4.3% | 320,542 | 0.0% | 0.32% | -12.6% |
Q3 2020 | $1,125,000 | -23.7% | 320,542 | 0.0% | 0.37% | -13.9% |
Q2 2020 | $1,474,000 | +38.9% | 320,542 | 0.0% | 0.42% | -4.1% |
Q1 2020 | $1,061,000 | -51.8% | 320,542 | -11.1% | 0.44% | -41.4% |
Q4 2019 | $2,203,000 | +46.6% | 360,542 | 0.0% | 0.76% | +33.8% |
Q3 2019 | $1,503,000 | -42.7% | 360,542 | +80.3% | 0.56% | -42.7% |
Q2 2019 | $2,624,000 | +280.8% | 200,013 | +175.9% | 0.99% | +232.0% |
Q1 2019 | $689,000 | +123.0% | 72,500 | -27.5% | 0.30% | +92.9% |
Q4 2018 | $309,000 | – | 100,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
Platform Technology Partners | 141,025 | $474,000 | 0.23% |
Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |